Evaluation of Cytomegalovirus (CMV)-specific immunoglobulins as serologic markers for CMV infection in HIV infected patients

被引:0
|
作者
Mehrkhani, F. [1 ]
Jabbari, H. [2 ]
Fattahi, F. [3 ]
Kourorian, Z. [3 ]
Jam, S. [1 ]
Badie, Moradmand B. [1 ]
Mohraz, M. [1 ]
机构
[1] Univ Tehran Med Sci, Imam Khomeini Hosp, Iranian Res Ctr HIV AIDS, Tehran, Iran
[2] Univ Tehran Med Sci, Environm Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Children Med Ctr, Immunol Asthma & Allergy Res Inst, Tehran, Iran
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
214
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [21] Safety and preliminary efficacy of "Ready to administer" cytomegalovirus (CMV)-specific T cells for the treatment of patients with refractory CMV infection
    Tzannou, I.
    Kakarla, S.
    Watanabe, A.
    Leung, K. S.
    Martinez, C.
    Naik, S.
    Gottschalk, S.
    Gee, A. P.
    Grilley, B.
    Giroir, B.
    Vera, J. F.
    Leen, A. M.
    Omer, B.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S507 - S507
  • [22] Management of CMV retinitis in HIV infected patients
    Katlama, C
    GENITOURINARY MEDICINE, 1997, 73 (03): : 169 - 173
  • [23] Massive alveolar hemorrhage due to cytomegalovirus (CMV) and HIV infection
    Cortes, A.
    Pena, E.
    Vega, R.
    Reyes, G.
    Bautista, E.
    MEDICINA INTENSIVA, 2011, 35 (02) : 126 - 129
  • [24] Efficacy of cytomegalovirus specific immunoglobulins (cmv-ig) in reducing cmv reactivation in paediatric haematopoietic stem cell transplant
    Geurten, C.
    Ghinai, R.
    Munford, H.
    Cole, N.
    Norton, A.
    Lawson, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 292 - 293
  • [25] Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease
    Bronke, C
    Palmer, NM
    Jansen, CA
    Westerlaken, GHA
    Polstra, AM
    Reiss, P
    Bakker, M
    Miedema, F
    Tesselaar, K
    van Baarle, D
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (06): : 873 - 880
  • [26] Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types
    Zhao, Min
    Zhuo, Chuanshang
    Li, Qinguang
    Liu, Lijuan
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 2710 - 2715
  • [27] Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia
    Mattioni, Sarah
    Pavie, Juliette
    Porcher, Raphael
    Scieux, Catherine
    Denis, Blandine
    De Castro, Nathalie
    Simon, Francois
    Molina, Jean-Michel
    INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (05) : 306 - 312
  • [28] Incidence of cytomegalovirus (CMV) retinitis in fellow eyes of HIV-infected patients with unilateral CMV retinitis treated with intravitreal ganciclovir injections
    Alsberge, Joseph B.
    Ausayakhun, Somsanguan
    Lirawison, Choeng
    Liu, Yingna
    Yen, Michael
    Margolis, Todd P.
    Keenan, Jeremy D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] CYTOMEGALOVIRUS (CMV)-SPECIFIC INTRAVENOUS IMMUNOGLOBULIN FOR THE PREVENTION OF PRIMARY CMV INFECTION AND DISEASE AFTER MARROW TRANSPLANT
    BOWDEN, RA
    FISHER, LD
    ROGERS, K
    CAYS, M
    MEYERS, JD
    JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03): : 483 - 487
  • [30] SPECIFIC ANTI-CMV IMMUNOGLOBULINS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN BONE-MARROW TRANSPLANT RECIPIENTS
    HUART, JJ
    BAUME, D
    JOUET, JP
    ANNALES DE MEDECINE INTERNE, 1987, 138 (05): : 372 - 374